Self-Nanoemulsifying Drug Delivery System (SNEDDS) Using Lipophilic Extract of Viscum album subsp. austriacum (Wiesb.) Vollm
DOI: https://doi.org/10.2147/ijn.s464508
IF: 7.033
2024-06-15
International Journal of Nanomedicine
Abstract:Camila Faria de Amorim Pereira, 1, &ast Michelle Nonato de Oliveira Melo, 1, &ast Vania Emerich Bucco de Campos, 2 Ivania Paiva Pereira, 1 Adriana Passos Oliveira, 1 Mariana Souza Rocha, 1 João Vitor da Costa Batista, 3, 4 Valter Paes de Almeida, 5 Irailson Thierry Monchak, 5 Eduardo Ricci-Júnior, 6 Rafael Garrett, 7 Aline Gabrielle Alves Carvalho, 7 Jane Manfron, 5 Stephan Baumgartner, 3, 8, 9 Carla Holandino 1, 3 1 Multidisciplinary Laboratory of Pharmaceutical Sciences, Faculty of Pharmacy, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 2 Department of Pharmacy, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil; 3 Society for Cancer Research, Hiscia Institute, Arlesheim, Switzerland; 4 Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland; 5 Postgraduate Program in Pharmaceutical Sciences, Universidade Estadual de Ponta Grossa, Ponta Grossa, Paraná, Brazil; 6 Galenic Development Laboratory (LADEG), Department of Drugs and Medicines, Faculty of Pharmacy, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 7 Metabolomics Laboratory, Chemistry Institute, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 8 Institute of Integrative Medicine, University of Witten/Herdecke, Herdecke, Germany; 9 Institute of Complementary and Integrative Medicine, University of Bern, Bern, Switzerland &astThese authors contributed equally to this work Correspondence: Carla Holandino, Multidisciplinary Laboratory of Pharmaceutical Sciences, Universidade Federal do Rio de Janeiro, Faculty of Pharmacy, Block B basement, Room 34, 373, Carlos Chagas Filho Avenue, Cidade Universitária, Rio de Janeiro, RJ, 21941-902, Brazil, Email Stephan Baumgartner, Institute of Complementary and Integrative Medicine, University of Bern, Bern, Switzerland, Email Background and Purpose: Natural products are potential sources of anticancer components. Among various species, the lipophilic extract of the Viscum album subsp. austriacum (Wiesb.) Vollm. (VALE) has shown promising therapeutic potential. The present work aimed to qualify the plant source and characterize the extract's chemical profile. In addition, a self-nanoemulsifying drug delivery system (SNEDDS) containing VALE (SNEDDS-VALE) was developed. Methods: V. album subsp. austriacum histochemistry was performed, and the chemical profile of VALE was analyzed by GC-MS. After the SNEEDS-VALE development, its morphology was visualized by transmission electron microscopy (TEM), while its stability was evaluated by the average droplet size, polydispersity index (PdI) and pH. Lastly, SNEDDS-VALE chemical stability was evaluated by LC-DAD-MS. Results: The histochemical analysis showed the presence of lipophilic compounds in the leaves and stems. The major compound in the VALE was oleanolic acid, followed by lupeol acetate and ursolic acid. SNEDDS was composed of medium chain triglyceride and Kolliphor ® RH 40 (PEG-40 hydrogenated castor oil). A homogeneous, isotropic and stable nanoemulsion was obtained, with an average size of 36.87 ± 1.04 nm and PdI of 0.14 ± 0.02, for 14 weeks. Conclusion: This is the first histochemistry analysis of V. album subsp. austriacum growing on Pinus sylvestris L . which provided detailed information regarding its lipophilic compounds. A homogeneous, isotropic and stable SNEDDS-VALE was obtained to improve the low water solubility of VALE. Further, in vitro and in vivo experiments should be performed, in order to evaluate the antitumoral potential of SNEDDS-VALE. Keywords: Viscum album subsp. austriacum , mistletoe, lipophilic extract, oleanolic acid, SNEDDS Graphical Among several parasitic plants, the European mistletoe ( Viscum album L.) is one of the most studied. 1,2 This species has many distinct host trees, which leads to different chemical metabolic profiles, 3–5 and biological activities. 6 Medicines from the V. album have been used worldwide in complementary cancer therapy since 1917, mainly in central Europe. 7 The commercial products are generally prepared by aqueous extractions that are rich in lectins and viscotoxins. 8,9 These aqueous-soluble compounds are capable of inducing cytotoxic effects on tumor cell lines in addition to induce immunological response. 8, -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology